Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02639091 |
| Title | Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Chicago | Illinois | 60637 | United States | Details | ||
| Bethesda | Maryland | 20892 | United States | Details | ||
| Detroit | Michigan | 48202 | United States | Details | ||
| Charleston | South Carolina | 29425 | United States | Details | ||
| Milano | Lombardia | 20089 | Italy | Details | ||
| Milano | Lombardia | 20133 | Italy | Details |